Tech & devices

  • Solving for women isn’t niche. It’s how you build better tech

    By Karishma Patel, Cofounder & Chief Brand Officer at Ema Let’s get this out of the way: Women’s health isn’t a niche. It’s the blueprint. Not just for healthcare. For technology, period. We’ve been sold the idea that designing for women is somehow “specialised,” when in reality it’s the most rigorous, emotionally complex, and systemically [...]

  • European healthcare professionals react to new ultrasound technology

    European ultrasound specialists have responded to the launch of an advanced ultrasound system by international health technology provider Mindray. The Resona A20, unveiled in Naples late last year at the 35th congress of the European Federation of Ultrasound Societies in Medicine and Biology, was developed by Mindray to allow healthcare professionals to have a “deeper [...]

  • Breastfeeding device measures babies’ milk intake in real time

    While breastfeeding has many benefits for a mother and her baby, it has one major drawback: It’s incredibly difficult to know how much milk the baby is consuming. To take the guesswork out of breastfeeding, an interdisciplinary team of engineers, neonatologists and pediatricians at Northwestern University has developed a new wearable device that can provide [...]

  • First at-home cervical cancer screening device receives US regulatory approval

    US regulators have approved the first at-home vaginal self-collection device for cervical cancer screening, offering women an alternative to in-clinic exams. The Teal Wand, developed by women's health company Teal Health, allows individuals to collect samples at home without a speculum and send them to a certified laboratory for testing using the same methods as in-clinic [...]

  • International consortium launches US$1m AI grant to tackle ovarian cancer

    An international group of ovarian cancer research charities has launched a new AI-focused grant aimed at accelerating progress in one of the most underfunded and least survivable cancers affecting women worldwide. The Global Ovarian Cancer Research Consortium — a collaboration between organisations in the US, UK, Canada and Australia — has announced a US$1m AI [...]

  • FDA de novo authorisation for first-ever OTC PCR test for women’s sexual health

    Diagnostics company Visby Medical has been granted De Novo authorisation for the Visby Medical Women's Sexual Health Test by the U.S. Food and Drug Administration (FDA) for Over the Counter (OTC) use. The groundbreaking test enables rapid and private at-home testing for chlamydia, gonorrhea, and trichomoniasis — the three most common curable sexually transmitted infections [...]

  • Breakthrough AI solution to advance early detection in women’s health

    Covera Health has announced the launch of Protect Her - an AI-powered solution designed to enhance early detection of critical health conditions predominantly impacting women ages 40 and up. Protect Her utilises latest advances in radiology AI to identify early signs of breast cancer, cardiovascular disease and osteoporosis during routine scans that women are already [...]

  • AI-powered mammograms: a new window into heart health

    Mammograms used in combination with AI may reveal much more than cancer,  but can also be used to assess the amount of calcium build up in the arteries within breast tissue - an indicator of cardiovascular health, a new study shows. While breast artery calcifications can be seen on mammogram images, radiologists do not typically [...]

  • US funding boost to lower barriers to sexual and reproductive care

    Women's digital health company Twentyeight Health has secures US$10m funding to expand its services in order to help lower barriers to sexual and reproductive care in the US. Twentyeight Health provides telemedicine consultations, at-home deliveries, and ongoing access to providers for services like birth control and herpes treatments, particularly in underserved communities. "45 per cent [...]

  • World-first at-home test delivers more accurate gestational diabetes diagnoses

    Standard NHS procedures for processing gestational diabetes blood sugar tests lead to more than 50 per cent of cases being missed, shows research, which could lead to serious complications for mothers. Such complications include the development of preeclampsia, and for the baby an increased risk of admission to the Neonatal Intensive Care Unit for breathing [...]